Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

CYCLAPEN-W

CYCLACILLIN

Standard Dose
250MG/5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview CYCLAPEN-W is listed in Drugs@FDA under application 050508 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient CYCLACILLIN Form and strength FOR SUSPENSION;ORAL - 250MG/5ML Sponsor WYETH AYERST Submission history Latest submission status date: 1985-08-12 00:00:00.

Structured Monograph

Clinical summary

Approval overview CYCLAPEN-W is listed in Drugs@FDA under application 050508 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CYCLACILLIN Form and strength FOR SUSPENSION;ORAL - 250MG/5ML Sponsor WYETH AYERST Submission history Latest submission status date: 1985-08-12 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
CYCLAPEN-W (CYCLACILLIN) | Drug Monograph | MedicHelpline